The American College of Cardiology (ACC) has recognized Stormont Vail Health for its demonstrated expertise and commitment in treating patients receiving transcatheter valve repair and replacement (TAVR) procedures. Stormont Vail was awarded the Transcatheter Valve Certification in January based on evaluation of the staff’s ability to meet standards for multidisciplinary teams, formalized training, shared decision-making and registry performance.
“This certification further illustrates that when our patients choose Stormont Vail for their heart care they will be treated by highly skilled and experienced providers,” Jack Jones, M.D., medical director, Stormont Vail Health.
The ACC’s Transcatheter Valve Certification is an external review and certification process that pairs with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in established national clinical databases such as the STS/ACC TVT Registry is required for hospitals interested in achieving Transcatheter Valve Certification.
“Stormont Vail has demonstrated its commitment to providing northeast Kansas with excellent heart care,” said Phillip D. Levy, MD, FACC, chair of the ACC Accreditation Management Board. “ACC Accreditation Services is proud to award Stormont Vail with Transcatheter Valve Certification.”
The certification uses established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification learn best practices for implementing evidence-based medicine to support patient-centered decision-making and can track key performance metrics to better identify opportunities for improvement.
The ACC offers U.S. and international hospitals like Stormont Vail access to a comprehensive suite of cardiac accreditation services designed to optimize patient outcomes and improve hospital financial performance. These services are focused on all aspects of cardiac care, including transcatheter valve therapies.